TIDMCSRT
FORM 8.3 - Amendment to Purchase
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose CONSORT MEDICAL PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this
and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 29 January 2020
(f) In addition to the company in 1(c) NO
above, is the discloser making
disclosures in respect of any
other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant 10p ordinary
security:
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 4,173,912 8.46% 12,389 0.03%
(2) Cash-settled derivatives:
10,685 0.02% 3,278,385 6.64%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 4,184,597 8.48% 3,290,774 6.67%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors'
and other employee options)
Class of relevant security in relation
to which subscription right exists:
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
10p ordinary Purchase 685 10.0499 GBP
10p ordinary Purchase 2,520 10.0000 GBP
10p ordinary Purchase 7,964 10.0512 GBP
10p ordinary Purchase 175,000 10.0275 GBP
10p ordinary Purchase 340,000 10.0225 GBP
10p ordinary Sale 20 10.0000 GBP
10p ordinary Sale 244 10.0401 GBP
10p ordinary Sale 624 10.0505 GBP
10p ordinary Sale 10,432 10.0009 GBP
10p ordinary Sale 12,500 10.0250 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
10p ordinary SWAP Long 216 10.0453 GBP
10p ordinary SWAP Long 388 10.0194 GBP
10p ordinary SWAP Long 10,000 9.9990 GBP
10p ordinary SWAP Long 12,592 10.0239 GBP
10p ordinary SWAP Short 2 10.0000 GBP
10p ordinary SWAP Short 79 10.0379 GBP
10p ordinary CFD Short 7,964 10.0512 GBP
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number Exercise Type Expiry date Option
relevant description purchasing, of price e.g. money
security e.g. selling, securities per unit American, paid/
call varying to European received
option etc. which etc. per
option unit
relates
(ii) Exercise
Class of relevant Product Exercising/ Number Exercise price
security description exercised of securities per unit
e.g. call against
option
(d) Other dealings (including subscribing for new
securities)
Class of relevant security Nature of dealing Details Price per unit (if
e.g. subscription, applicable)
conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement,
or any agreement or understanding,
formal or informal, relating to relevant
securities which may be an inducement to
deal or refrain from dealing entered into by
the person making the disclosure and any
party to the offer or any person acting
in concert with a party to the offer:
Irrevocable commitments and letters of intent
should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or
understanding, formal or informal,
between the person making the disclosure
and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any
relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements
or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open NO
Positions) attached?
Date of disclosure: 3 Feb 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does
not need to be included, provided contact information has been
provided to the Panel's Market Surveillance Unit.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200203005595/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
February 03, 2020 11:24 ET (16:24 GMT)
Consort Medical (LSE:CSRT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Consort Medical (LSE:CSRT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
